Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Helix BioMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2002 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '12 Sep 30, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2002 - 2006 |
| Revenue | 2.07 | 1.89 | 0.85 | 0.39 | 0.56 | 0.46 | Upgrade
|
| Revenue Growth (YoY) | 14.56% | 122.07% | 117.67% | -30.49% | 21.32% | 553.99% | Upgrade
|
| Cost of Revenue | 0.64 | 0.73 | 0.26 | 0.2 | 0.26 | 0.14 | Upgrade
|
| Gross Profit | 1.42 | 1.16 | 0.59 | 0.19 | 0.31 | 0.33 | Upgrade
|
| Selling, General & Admin | 3.37 | 2.95 | 2.68 | 2.56 | 2.89 | 2.89 | Upgrade
|
| Research & Development | 0.38 | 0.5 | 0.75 | 0.72 | 0.83 | 0.78 | Upgrade
|
| Operating Expenses | 3.85 | 3.56 | 3.55 | 3.41 | 3.85 | 3.84 | Upgrade
|
| Operating Income | -2.42 | -2.4 | -2.96 | -3.22 | -3.54 | -3.52 | Upgrade
|
| Interest Expense | -0.11 | - | -0.89 | -0.57 | -1.04 | - | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.06 | 0.08 | Upgrade
|
| Earnings From Equity Investments | -0.04 | -0.09 | -0.07 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.58 | -2.49 | -3.91 | -3.78 | -4.53 | -3.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | -0.01 | 0 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -3.81 | - | 0.01 | - | Upgrade
|
| Pretax Income | -2.58 | -2.49 | -7.71 | -3.78 | -4.52 | -3.43 | Upgrade
|
| Net Income | -2.58 | -2.49 | -7.71 | -3.78 | -4.52 | -3.43 | Upgrade
|
| Net Income to Common | -2.58 | -2.49 | -7.71 | -3.78 | -4.52 | -3.43 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 10.06% | 83.31% | 5.73% | - | 2.04% | 12.52% | Upgrade
|
| EPS (Basic) | -15.59 | -15.02 | -85.28 | -44.15 | -52.81 | -40.98 | Upgrade
|
| EPS (Diluted) | -15.59 | -15.02 | -85.28 | -44.15 | -52.81 | -40.98 | Upgrade
|
| Free Cash Flow | -1.83 | -2.3 | -2.8 | -3.09 | -3.15 | -3.24 | Upgrade
|
| Free Cash Flow Per Share | -11.04 | -13.87 | -30.99 | -36.12 | -36.89 | -38.65 | Upgrade
|
| Gross Margin | 68.96% | 61.23% | 69.41% | 49.77% | 54.63% | 70.15% | Upgrade
|
| Operating Margin | -117.30% | -127.12% | -347.10% | -822.43% | -629.65% | -758.41% | Upgrade
|
| Profit Margin | -125.06% | -131.58% | -905.36% | -964.82% | -802.22% | -740.18% | Upgrade
|
| Free Cash Flow Margin | -88.57% | -121.54% | -329.02% | -789.38% | -560.37% | -698.14% | Upgrade
|
| EBITDA | -2.33 | -2.3 | -2.84 | -3.09 | -3.41 | -3.34 | Upgrade
|
| EBITDA Margin | -112.72% | -121.35% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.09 | 0.11 | 0.11 | 0.13 | 0.13 | 0.17 | Upgrade
|
| EBIT | -2.42 | -2.4 | -2.96 | -3.22 | -3.54 | -3.52 | Upgrade
|
| EBIT Margin | -117.30% | -127.12% | - | - | - | - | Upgrade
|
| Revenue as Reported | 2.07 | 1.89 | 0.85 | 0.39 | 0.56 | 0.46 | Upgrade
|
| Advertising Expenses | - | 0.15 | 0.04 | 0.03 | 0.02 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.